Oric Pharmaceuticals Inc.(ORIC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ORIC Oric Pharmaceuticals Inc.

休市中 12-12 16:00:00 EST

9.38

-0.31

-3.20%

盘后9.59

+0.21+2.24%

18:32 EST

最高9.74	最低9.33	成交量103.59万
今开9.68	昨收9.69	日振幅4.23%
总市值9.14亿	流通市值5.69亿	总股本9,739万
成交额983.17万	换手率1.71%	流通股本6,066万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ORIC","market":"US","secType":"STK","nameCN":"Oric Pharmaceuticals Inc.","latestPrice":9.38,"timestamp":1765573200000,"preClose":9.69,"halted":0,"volume":1035868,"hourTrading":{"tag":"盘后","latestPrice":9.59,"preClose":9.38,"latestTime":"18:32 EST","volume":60176,"amount":570186.515,"timestamp":1765582331135},"delay":0,"floatShares":60659100,"shares":97389279,"eps":-1.69572,"marketStatus":"休市中","change":-0.31,"latestTime":"12-12 16:00:00 EST","open":9.68,"high":9.74,"low":9.33,"amount":9831680.083264,"amplitude":0.042312,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.69572,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1587700800000,"exchange":"NASDAQ","adjPreClose":9.69,"preHourTrading":{"tag":"盘前","latestPrice":9.8,"preClose":9.69,"latestTime":"09:03 EST","volume":1664,"amount":16173.282944,"timestamp":1765548208807},"postHourTrading":{"tag":"盘后","latestPrice":9.59,"preClose":9.38,"latestTime":"18:32 EST","volume":60176,"amount":570186.515,"timestamp":1765582331135},"volumeRatio":0.7917012600339736,"impliedVol":1.2333,"impliedVolPercentile":0.676},"requestUrl":"/m/hq/s/ORIC/wiki","defaultTab":"wiki","newsList":[{"id":"1117121799","title":"Oric® Pharmaceuticals在2025年ESMO亚洲大会上宣布Enozertinib（Oric-114）关于EGFR非典型和EGFR外显子20非小细胞肺癌的最新口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1117121799","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117121799?lang=zh_cn&edition=full","pubTime":"2025-12-04 05:02","pubTimestamp":1764795742,"startTime":"0","endTime":"0","summary":"Oric® Pharmaceuticals在2025年ESMO亚洲大会上宣布Enozertinib（Oric-114）关于EGFR非典型和EGFR外显子20非小细胞肺癌的最新口头报告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORIC","BK4139"],"gpt_icon":0},{"id":"1128963466","title":"Oric Pharmaceuticals第三季度净收入为-3258.7万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128963466","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128963466?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:45","pubTimestamp":1763574350,"startTime":"0","endTime":"0","summary":"11月13日 - Oric Pharmaceuticals第三季度运营支出为3667.1万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORIC"],"gpt_icon":0},{"id":"1189416261","title":"Oric Pharmaceuticals公布根据纳斯达克上市规则5635(C)(4)的诱因授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1189416261","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189416261?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:13","pubTimestamp":1763572428,"startTime":"0","endTime":"0","summary":"Oric Pharmaceuticals Inc. ::*ORIC PHARMACEUTICALS公布根据纳斯达克上市规则5635(C)(4)的诱因授予","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORIC","BK4139"],"gpt_icon":0},{"id":"1187798230","title":"Oric® Pharmaceuticals宣布Oric-944 1B期临床试验剂量探索部分完成，并持续展现潜在的最佳疗效与安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1187798230","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187798230?lang=zh_cn&edition=full","pubTime":"2025-11-14 05:06","pubTimestamp":1763067973,"startTime":"0","endTime":"0","summary":"Oric® Pharmaceuticals宣布Oric-944 1B期临床试验的剂量探索部分已完成，并继续展现出潜在的最佳疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORIC"],"gpt_icon":0},{"id":"2558157942","title":"Oric Pharmaceuticals, Inc.盘中异动 急速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558157942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558157942?lang=zh_cn&edition=full","pubTime":"2025-08-09 01:46","pubTimestamp":1754675195,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日01时46分，Oric Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.01%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Hyperion Defi, Inc.、Alector, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃，换手率分别为654.25%、172.55%、103.35%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、180 Life Sciences Corp C/Wts 07/11/2025、Longeveron Inc.，振幅分别为75.81%、73.00%、49.61%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080901463594d831e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080901463594d831e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2557303669","title":"Oric Pharmaceuticals, Inc.盘中异动 股价大跌5.17%报9.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557303669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557303669?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:26","pubTimestamp":1754490394,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时26分，Oric Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.17%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Bioxcel Therapeutics, Inc.、Biomx Inc.、诺瓦瓦克斯医药涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为543.34%、344.06%、42.70%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Fortrea Holdings Inc.，振幅分别为45.15%、44.74%、32.09%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622263494d3916f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622263494d3916f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2556830257","title":"Oric Pharmaceuticals, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556830257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556830257?lang=zh_cn&edition=full","pubTime":"2025-08-01 02:15","pubTimestamp":1753985728,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日02时15分，Oric Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.04%。截至发稿，该股报10.17美元/股，成交量35.4136万股，换手率0.42%，振幅5.23%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.94%。其相关个股中，Soligenix, Inc.、Silexion Therapeutics Corp、Jyong Biotech Ltd.涨幅较大，Soligenix, Inc.、Psyence Biomedical Ltd.、Onconetix, Inc.较为活跃，换手率分别为10925.06%、5110.42%、4875.21%，振幅较大的相关个股有Soligenix, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为297.60%、97.88%、97.44%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801021528a6cc1ec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801021528a6cc1ec0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2555052683","title":"Oric Pharmaceuticals, Inc.盘中异动 股价大跌5.01%报10.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555052683?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:44","pubTimestamp":1753796650,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时44分，Oric Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.01%。截至发稿，该股报10.62美元/股，成交量12.1247万股，换手率0.14%，振幅6.53%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Salarius Pharmaceuticals, Inc.、Surrozen Inc C/Wts 01/08/2031 、Scinai Immunotherapeutics Ltd涨幅较大，Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为3227.56%、1870.16%、1288.57%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、Scinai Immunotherapeutics Ltd，振幅分别为98.49%、45.70%、43.41%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921441097258a9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921441097258a9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2550673612","title":"Oric Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550673612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550673612?lang=zh_cn&edition=full","pubTime":"2025-07-11 02:55","pubTimestamp":1752173736,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日02时55分，Oric Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.23%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Q32 Bio Inc.、Pelthos Therapeutics Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Cognition Therapeutics, Inc.、Q32 Bio Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为384.62%、358.42%、345.29%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Q32 Bio Inc.、Pelthos Therapeutics Inc.，振幅分别为91.19%、90.07%、85.25%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711025537a6a21c96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711025537a6a21c96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2550659986","title":"Oric Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550659986?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:54","pubTimestamp":1752072876,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时54分，Oric Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.03%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.20%。其相关个股中，Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为1139.65%、713.28%、533.69%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Prokidney Corp.，振幅分别为173.13%、112.02%、59.79%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225436a4409994&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225436a4409994&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2546760973","title":"Oric Pharmaceuticals, Inc.6月26日成交额为1819.04万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546760973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546760973?lang=zh_cn&edition=full","pubTime":"2025-06-27 12:25","pubTimestamp":1750998327,"startTime":"0","endTime":"0","summary":"美东时间2025年6月26日，Oric Pharmaceuticals, Inc.成交额为1819.04万美元，成交额较昨日增加118.93%，当日成交量为173.98万股。Oric Pharmaceuticals, Inc.于2025年6月26日涨2.64%，报10.5美元，该股过去5个交易日涨13.88%，年初至今涨30.11%，过去60日涨88.17%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-26|1819.04万|118.93%|173.98万|#|2025-06-25|830.86万|-34.72%|79.43万|#|2025-06-24|1272.72万|60.00%|119.73万|#|2025-06-23|795.46万|-45.54%|81.66万|#|2025-06-20|1460.63万|110.59%|157.14万|ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627122532a4c04ae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627122532a4c04ae4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC","BK4139"],"gpt_icon":0},{"id":"2546464264","title":"Oric Pharmaceuticals, Inc.6月24日成交额为1272.72万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546464264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546464264?lang=zh_cn&edition=full","pubTime":"2025-06-25 12:38","pubTimestamp":1750826323,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Oric Pharmaceuticals, Inc.成交额为1272.72万美元，成交额较昨日增加60.00%，当日成交量为119.73万股。Oric Pharmaceuticals, Inc.于2025年6月24日涨4.9%，报10.49美元，该股过去5个交易日涨11.48%，年初至今涨29.99%，过去60日涨66.77%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-24|1272.72万|60.00%|119.73万|#|2025-06-23|795.46万|-45.54%|81.66万|#|2025-06-20|1460.63万|110.59%|157.14万|#|2025-06-18|693.58万|-6.33%|74.92万|#|2025-06-17|740.48万|-22.82%|80.85万|ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625123852a4bc9fce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625123852a4bc9fce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC","BK4139"],"gpt_icon":0},{"id":"2545448040","title":"Oric Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545448040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545448040?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:42","pubTimestamp":1750689777,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日22时42分，Oric Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.16%。截至发稿，该股报9.79美元/股，成交量13.66万股，换手率0.16%，振幅6.66%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.、Vor Biopharma Inc.涨幅较大，Indaptus Therapeutics, Inc.、Nucana Plc、Eyenovia, Inc.较为活跃，换手率分别为1503.70%、546.52%、312.04%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Indaptus Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为71.02%、64.31%、57.53%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623224257a719165e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623224257a719165e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2545102714","title":"Oric Pharmaceuticals, Inc.6月20日成交额为1460.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545102714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545102714?lang=zh_cn&edition=full","pubTime":"2025-06-21 12:34","pubTimestamp":1750480492,"startTime":"0","endTime":"0","summary":"美东时间2025年6月20日，Oric Pharmaceuticals, Inc.成交额为1460.63万美元，成交额较昨日增加110.59%，当日成交量为157.14万股。Oric Pharmaceuticals, Inc.于2025年6月20日涨0.98%，报9.31美元，该股过去5个交易日跌3.72%，年初至今涨15.37%，过去60日涨37.93%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-20|1460.63万|110.59%|157.14万|#|2025-06-18|693.58万|-6.33%|74.92万|#|2025-06-17|740.48万|-22.82%|80.85万|#|2025-06-16|959.46万|41.21%|101.13万|#|2025-06-13|679.47万|-12.98%|71.41万|ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621123453a7159d21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621123453a7159d21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC","BK4139"],"gpt_icon":0},{"id":"2544901028","title":"Oric Pharmaceuticals, Inc.盘中异动 大幅上涨5.09%报9.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544901028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544901028?lang=zh_cn&edition=full","pubTime":"2025-06-19 00:35","pubTimestamp":1750264504,"startTime":"0","endTime":"0","summary":"北京时间2025年06月19日00时35分，Oric Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.09%。截至发稿，该股报9.49美元/股，成交量36.0377万股，换手率0.42%，振幅6.98%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，Aptevo Therapeutics Inc.、Immuneering Corporation、Caris Life Sciences Inc涨幅较大，Aptevo Therapeutics Inc.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃，换手率分别为16208.70%、1023.14%、654.31%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Immatics N V C/Wts 01/07/2025 、Liminatus Pharma Inc C/Wts 30/04/2030 ，振幅分别为294.68%、97.75%、60.00%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619003504a710dc10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619003504a710dc10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2543549069","title":"Oric Pharmaceuticals, Inc.盘中异动 大幅拉升5.01%报9.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543549069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543549069?lang=zh_cn&edition=full","pubTime":"2025-06-13 01:29","pubTimestamp":1749749362,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日01时29分，Oric Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.01%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Nucana Plc、Polyrizon Ltd.、Klotho Neurosciences, Inc.较为活跃，换手率分别为2698.92%、812.97%、353.26%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.，振幅分别为256.24%、169.83%、87.67%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613012923977cea38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613012923977cea38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2518755942","title":"Oric Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518755942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518755942?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:31","pubTimestamp":1741617117,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时31分，Oric Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.25%。截至发稿，该股报7.58美元/股，成交量7.5166万股，换手率0.11%，振幅3.63%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3460.23%、733.65%、526.63%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.，振幅分别为41.36%、40.33%、40.24%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223157a26a3bd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223157a26a3bd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2516631766","title":"Oric Pharmaceuticals, Inc.盘中异动 临近收盘快速下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516631766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516631766?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:41","pubTimestamp":1741034475,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时41分，Oric Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.23%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Celularity Inc C/Wts 16/07/2026 涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为215.94%、187.94%、164.66%，振幅较大的相关个股有Radiopharm Theranostics Limited、Entero Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为119.50%、70.53%、64.88%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044115989a61a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044115989a61a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2514330533","title":"Oric Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514330533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514330533?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:55","pubTimestamp":1740689725,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时55分，Oric Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.06%。截至发稿，该股报7.88美元/股，成交量67.988万股，换手率0.96%，振幅8.43%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1954.27%、423.50%、197.98%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045526abdfc290&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045526abdfc290&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2514857703","title":"小摩：维持ORIC Pharmaceuticals(ORIC.US)评级，由增持调整至增持评级, 目标价由21.00美元调整至22.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514857703","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514857703?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:23","pubTimestamp":1740587009,"startTime":"0","endTime":"0","summary":"小摩：维持ORIC Pharmaceuticals(ORIC.US)评级，由增持调整至增持评级, 目标价由21.00美元调整至22.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27002348413728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ORIC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oricpharma.com","stockEarnings":[{"period":"1week","weight":-0.1473},{"period":"1month","weight":-0.2484},{"period":"3month","weight":-0.1299},{"period":"6month","weight":-0.026},{"period":"1year","weight":0.1127},{"period":"ytd","weight":0.1623}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ORIC Pharmaceuticals, Inc.在特拉华州注册，成立于2014年8月。该公司是临床阶段的生物制药公司，致力于通过克服癌症抵抗力来改善患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.002864},{"month":2,"riseRate":0.4,"avgChangeRate":-0.079553},{"month":3,"riseRate":0.4,"avgChangeRate":-0.098966},{"month":4,"riseRate":0.2,"avgChangeRate":-0.164176},{"month":5,"riseRate":0.666667,"avgChangeRate":0.07899},{"month":6,"riseRate":0.666667,"avgChangeRate":0.141043},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.000511},{"month":8,"riseRate":0.666667,"avgChangeRate":0.090659},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.048915},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.0811},{"month":11,"riseRate":0.666667,"avgChangeRate":0.167402},{"month":12,"riseRate":0.5,"avgChangeRate":0.078385}],"exchange":"NASDAQ","name":"Oric Pharmaceuticals Inc.","nameEN":"Oric Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Oric Pharmaceuticals Inc.(ORIC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Oric Pharmaceuticals Inc.(ORIC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Oric Pharmaceuticals Inc.,ORIC,Oric Pharmaceuticals Inc.股票,Oric Pharmaceuticals Inc.股票老虎,Oric Pharmaceuticals Inc.股票老虎国际,Oric Pharmaceuticals Inc.行情,Oric Pharmaceuticals Inc.股票行情,Oric Pharmaceuticals Inc.股价,Oric Pharmaceuticals Inc.股市,Oric Pharmaceuticals Inc.股票价格,Oric Pharmaceuticals Inc.股票交易,Oric Pharmaceuticals Inc.股票购买,Oric Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Oric Pharmaceuticals Inc.(ORIC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Oric Pharmaceuticals Inc.(ORIC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}